Physician profile
Ashley E Balaker
NPI 1427387547
$2,075.53
in general payments reported to CMS, 2019-2025
23 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $439 · 2021: $451 · 2022: $226 · 2023: $141 · 2024: $172 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $428.02 | 2019-2025 | |
| Intersect Ent, INC. | $293.52 | 2019-2021 | |
| Genzyme Corporation | $247.19 | 2021-2025 | |
| Glaxosmithkline, LLC. | $180.46 | 2021-2025 | Nucala |
| Cochlear Americas | $142.89 | 2019-2024 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
| Stryker Corporation | $137.17 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $69.34 | 2021 | |
| Boston Scientific Corporation | $58.97 | 2019 | |
| Karl Storz Endoscopy-America | $57.47 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.93 | 2023-2025 | Cuvitru, Hyqvia |
| Baxter Healthcare | $49.24 | 2024 | Perclot |
| Astrazeneca Pharmaceuticals LP | $46.51 | 2022 | |
| Covidien LP | $45.55 | 2020 | |
| Acclarent, INC | $41.55 | 2019 | |
| Smith+Nephew, INC. | $36.85 | 2025 | Tula, Halo |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $30.60 | 2021 | |
| Abbvie INC. | $30.01 | 2023 | Botox |
| Kaleo, INC. | $26.58 | 2021 | |
| Aerin Medical INC. | $24.41 | 2024 | |
| Medtronic USA, INC. | $24.26 | 2020 | |
| Csl Behring | $21.02 | 2020 | |
| Novartis Pharmaceuticals Corporation | $17.99 | 2023 | |
| Glenmark Therapeutics INC. | $14.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Balaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.